BlackRock Group’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$979K Buy
31,892
+2,451
+8% +$106K ﹤0.01% 2141
2016
Q3
$1.97M Sell
29,441
-814
-3% -$41.2K ﹤0.01% 1635
2016
Q2
$902K Buy
30,255
+633
+2% +$19.8K ﹤0.01% 2017
2016
Q1
$870K Buy
29,622
+7,869
+36% +$356K ﹤0.01% 2002
2015
Q4
$1.71M Sell
21,753
-72,891
-77% -$5.72M ﹤0.01% 1582
2015
Q3
$7.13M Sell
94,644
-39,295
-29% -$3.72M ﹤0.01% 997
2015
Q2
$15.6M Buy
133,939
+121,665
+991% +$22M 0.01% 859
2015
Q1
$2.9M Sell
12,274
-25,464
-67% -$5.44M ﹤0.01% 1320
2014
Q4
$7.14M Sell
37,738
-7,792
-17% -$1.73M ﹤0.01% 1032
2014
Q3
$10.9M Sell
45,530
-8,470
-16% -$1.74M 0.01% 928
2014
Q2
$3.56M Buy
54,000
+654
+1% +$46.5K ﹤0.01% 1239
2014
Q1
$5.55M Buy
53,346
+20,947
+65% +$2.46M ﹤0.01% 1080
2013
Q4
$3.35M Sell
32,399
-39,701
-55% -$2.33M ﹤0.01% 1224
2013
Q3
$3.87M Sell
72,100
-47,900
-40% -$2.58M ﹤0.01% 1163
2013
Q2
$5.32M Buy
+120,000
New +$4.23M ﹤0.01% 984

Other funds holding PBYI